Pharmabiz

Sanofi's amlitelimab confirms its potential in atopic dermatitis

Sanofi's amlitelimab confirms its potential in atopic dermatitis: Paris Saturday, January 24, 2026, 10:00 Hrs [IST] Following the positive COAST 1 (clinical study identifier: NCT0 ...
Pharmabiz

China NMPA approves GSK’s Trelegy Ellipta for use in adults with uncontrolled asthma

China NMPA approves GSK’s Trelegy Ellipta for use in adults with uncontrolled asthma: London, UK Saturday, January 24, 2026, 09:00 Hrs [IST] GSK plc announced that China’s Nat ...
Pharmabiz

Guwahati to host pharma convention from Feb 26-28 as North East emerges as pharmaceutical hub

Peethaambaran Kunnathoor, Chennai Saturday, January 24, 2026, 08:00 Hrs [IST] ...
Pharmabiz

Amendment in NDCTR eases approvals by replacing prior permission with prior intimation: Dr Premnath Shenoy

Amendment in NDCTR eases approvals by replacing prior permission with prior intimation: Dr Premnath Shenoy: Nandita Vijayasimha, Bengaluru Saturday, January 24, 2026, 08:00 Hrs [I ...
Pharmabiz

Industry wants policy intervention through technology upgradation, quality infra and R&D in Budget 2026

Industry wants policy intervention through technology upgradation, quality infra and R&D in Budget 2026: Shardul Nautiyal, Mumbai Saturday, January 24, 2026, 08:00 Hrs [IST] As we ...
Pharmabiz

Indian healthcare sector witnessing significant evolution in its approach to mental health

Indian healthcare sector witnessing significant evolution in its approach to mental health: Nandita Vijayasimha, Bengaluru Saturday, January 24, 2026, 08:00 Hrs [IST] Indian healt ...
Pharmabiz

PDMA to approach health ministry with representation on revised Schedule M deadline

PDMA to approach health ministry with representation on revised Schedule M deadline: Gireesh Babu, New Delhi Saturday, January 24, 2026, 08:00 Hrs [IST] The Punjab Drug Manufactur ...
Pharmabiz

AIPA-Karnataka observes first anniversary of its formation focuses on ADR and AMR

AIPA-Karnataka observes first anniversary of its formation focuses on ADR and AMR: Our Bureau, Bengaluru Friday, January 23, 2026, 14:50 Hrs [IST] All India Government Private and ...
Pharmabiz

PulseSight Therapeutics completes patient enrolment in phase I trial of PST-611 to treat dry AMD/geographic atrophy

PulseSight Therapeutics completes patient enrolment in phase I trial of PST-611 to treat dry AMD/geographic atrophy: Paris, France Friday, January 23, 2026, 18:00 Hrs [IST] PulseS ...
Pharmabiz

Galderma provides update on arbitration case regarding neuromodulator research and development partnership

Galderma provides update on arbitration case regarding neuromodulator research and development partnership: Zug, Switzerland Friday, January 23, 2026, 16:00 Hrs [IST] Galderma, th ...
Pharmabiz

Akums strengthens presence in regulated markets with EU GMP approvals for 2 Haridwar plants

Akums strengthens presence in regulated markets with EU GMP approvals for 2 Haridwar plants: Our Bureau, Bengaluru Friday, January 23, 2026, 17:45 Hrs [IST] Akums Drugs & Pharmace ...
Pharmabiz

Telangana sets global ambition with Next Gen Life Sciences Policy 2026–30

The Government of Telangana, India unveiled its Next-Gen Life Sciences Policy 2026–30 at the World Economic Forum Annual Meeting in Davos, signalling the State’s intent to play a far more ...